Healthcare | May 23, 2022
Launch of joint research to collect a year’s worth of lifestyle data through wearable tracking device
Objective tracking data combined with cohort data to drive medicine of the future
Objective tracking data combined with cohort data to drive medicine of the future
The European Commission granted CMA in December 2021 for use of Nuvaxovid in individuals aged 18 and over, and Novavax filed for expanded CMA for use in adolescents aged 12 through 17 in March 2022
Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; approval granted more than two months ahead of USFDA’s Priority Review action date
The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe Covid-19
The curriculum has been curated for General Physicians working in Clinikk
Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022
Potential new treatment for progressive pulmonary fibrosis (PPF) builds on Boehringer Ingelheim’s leadership in lung fibrosis and will be further investigated in a phase III clinical trial program
The median progression free survival, increased from 19.2 months to 35.7 months when Sarclisa was added to carfilzomib and dexamethasone
The pharma companies will bring quality products at competitive prices to consumers in Oman and help bring down the cost of healthcare
AKS-452 is currently undergoing Phase II/III clinical testing in India as a primary vaccine; submission for Emergency Use Authorization (EUA) expected by Q3 2022
Subscribe To Our Newsletter & Stay Updated
